
Lucas Berenbrok, PharmD, MS, discussed pharmacy deserts and how closures around the US have the potential to impact public health.
Lucas Berenbrok, PharmD, MS, discussed pharmacy deserts and how closures around the US have the potential to impact public health.
A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.
Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.
Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.
Don Roosan, PharmD, PhD, joined Drug Topics to explore the future of ChatGPT in pharmacy practice and how AI is being used to manage patients’ medication regimens.
In an Axios analysis of US Senate lobbying disclosures from the past year, researchers explored the ongoing trends of how certain industries distribute influence among legislators.
Jennifer Zilka and Kyle Pudenz, DBA, from Cencora joined Drug Topics to discuss the role of independent pharmacies in addressing pharmacy deserts across the US.
The top reported barriers to providing buprenorphine included regulatory and administrative, operational and attitudinal, and patient-related challenges.
Using a novel pharmacy vulnerability index, researchers identified US regions at the most risk of becoming pharmacy deserts.
A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress’ failure to pass PBM reform at the end of 2024.
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
Representatives from Cencora’s Good Neighbor Pharmacy Network discussed legislation created to improve declining pharmacy rates and who is accountable for addressing pharmacy deserts.
Jennifer Zilka and Kyle Pudenz, DBA, introduced the issue of pharmacy deserts and discussed what has been driving store closures across the US.
The event will focus on clinical practice expansion for community pharmacies and how to make them a revenue-generating health care destination.
Don Roosan, PharmD, PhD, discussed the artificial intelligence of ChatGPT and how it is currently being used in clinical pharmacy practices.
Join Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, for the first episode of Dispensing Leadership, a new podcast from Drug Topics® and RPhAlly.
Clinical pharmacists were asked to provide interventions to improve their patients’ rate of not showing up to a pharmacy appointment.
The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.
Researchers conducted a survey asking pharmacists their perspectives on addressing patients’ social determinants of health.
Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients’ willingness to return for future immunization.
Researchers conducted a cross-sectional study to investigate the accessibility of over-the-counter naloxone and nonprescription syringes at community pharmacies.
Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Drug Topics to further discuss the Cut Hypertension Program and nontraditional roles within health care.
Researchers identified factors contributing to Medicaid Managed Care complexities and collected evidence of pharmacists’ ability to address patients’ health needs.
Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.
Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.
Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.
How pharmacies will pay for the Medicare Drug Price Negotiation Program
Explore key legislative actions changing pharmacy practice in 2025 and beyond.
The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.
What are some key strategies for keeping your pharmacy thriving in 2025?